Volume 87, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in

Transforming TB Diagnosis: Can Patients and Control Programs Afford to Wait?, Page 1 of 1

| /docserver/preview/fulltext/14761645/87/2/202-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2011. The Global Plan to STOP TB 2011–2015.Geneva:World Health Organization, (WHO/HTM/STB/2010.2).
    [Google Scholar]
  2. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD, 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 14951505.[Crossref]
    [Google Scholar]
  3. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M, 2012.Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64: 580588.[Crossref]
    [Google Scholar]
  4. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD, 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 10051015.[Crossref]
    [Google Scholar]
  5. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R, 2011. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 8: e1001067.[Crossref]
    [Google Scholar]
  6. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ, 2011. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11: 819824.[Crossref]
    [Google Scholar]
  7. Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, Kowour D, Rojas-Ponce G, Kroidl A, Maboko L, Heinrich N, Reither K, Hoelscher M, 2012. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 54: 13881396.[Crossref]
    [Google Scholar]
  8. Hillemann D, Rusch-Gerdes S, Boehme C, Richter E, 2011. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 49: 12021205.[Crossref]
    [Google Scholar]
  9. Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, Marais BJ, Warren RM, Wright CA, 2011. Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol 49: 39673970.[Crossref]
    [Google Scholar]
  10. Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal MP, Pascarella M, Borroni E, Mondo A, Piana F, Scarparo C, Coltella L, Lombardi G, Cirillo DM, 2012. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012 Jan 12 [Epub ahead of print].
    [Google Scholar]
  11. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C, 2011. Xpert MTB/RIF, a new pillar in the diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 49: 25402545.[Crossref]
    [Google Scholar]
  12. Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F, 2011. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8: e1001120.[Crossref]
    [Google Scholar]
  13. Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ, 1999. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy. J Acquir Immune Defic Syndr 2012: 11.
    [Google Scholar]
  14. Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RP, 2012. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy in South Africa: a model-based analysis. AIDS 26: 987995.[Crossref]
    [Google Scholar]
  15. Floyd K, Pantoja A, Glasziou P, 2010. Xpert MTB/RIF in the Global Plan 2011–2015. What Will It Cost? Geneva: World Health Organization Global Consultation on Xpert implementation.
    [Google Scholar]
  16. WHO, 2011. Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Geneva: World Health Organization, (WHO/HTM/TB/2011.4).
    [Google Scholar]
  17. WHO, 2011. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test: Technical and Operational “How-to”; Practical Considerations. Geneva: World Health Organization, (WHO/HTM/TB/2011.2).
    [Google Scholar]
  18. WHO, 2011. Checklist of Prerequisites to Country Implementation of Xpert MTB/RIF and Key Action Points at Country Level. Geneva: World Health Organization, (WHO/HTM/TB/2011.12).
    [Google Scholar]
  • Received : 18 Apr 2012
  • Accepted : 27 Apr 2012
  • Published online : 01 Aug 2012
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error